Curr Opin Hiv Aids

• 

  Publication Venue For

  • Context, COVID-19 and comorbidities: exploring emergent directions in syndemics and HIV research..  17:46-54. 2022
  • Engineering antibody-based molecules for HIV treatment and cure..  15:290-299. 2020
  • Syndemics of HIV with mental illness and other noncommunicable diseases: a research agenda to address the gap between syndemic theory and current research practice..  15:226-231. 2020
  • Neutralization tiers of HIV-1..  13:128-136. 2018
  • Cross-reactivity of HIV vaccine responses and the microbiome..  13:9-14. 2018
  • Features of cardiovascular disease in low-income and middle-income countries in adults and children living with HIV..  12:579-584. 2017
  • Lessons learned from human HIV vaccine trials..  12:216-221. 2017
  • Looking for fungi in all the right places: screening for cryptococcal disease and other AIDS-related mycoses among patients with advanced HIV disease..  12:139-147. 2017
  • HIV treatment cascade in MSM, people who inject drugs, and sex workers..  10:420-429. 2015
  • Antibodies for prevention of mother-to-child transmission of HIV-1..  10:177-182. 2015
  • HIV and the aging kidney..  9:340-345. 2014
  • Modulation of HIV-1 immunity by adjuvants..  9:242-249. 2014
  • A call to action for concentrated HIV epidemics..  9:95-100. 2014
  • Progress in HIV-1 vaccine development..  8:326-332. 2013
  • The changing epidemiology of HIV in 2013..  8:306-310. 2013
  • The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs..  7:563-568. 2012
  • Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries..  7:362-368. 2012
  • Biomarkers of impaired renal function..  5:524-530. 2010
  • Is developing an HIV-1 vaccine possible?.  5:362-367. 2010
  • Strategies for eliciting HIV-1 inhibitory antibodies..  5:421-427. 2010
  • Economic evaluation of ART in resource-limited countries..  5:225-231. 2010
  • HIV-1-specific antibody responses during acute and chronic HIV-1 infection..  4:373-379. 2009
  • Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination..  2:169-176. 2007
  • Kidney and central nervous system as reservoirs of HIV infection..  1:115-120. 2006
  • Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?.  4:347-351. 2009